|
1
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan CH, Li CF, Yang WL, Gao Y, Lee SW,
Feng Z, Huang HY, Tsai KK, Flores LG, Shao Y, et al: The Skp2-SCF
E3 ligase regulates Akt ubiquitination, glycolysis, herceptin
sensitivity, and tumorigenesis. Cell. 149:1098–1111. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pascal LE and Wang Z: Virtual drug design:
Skp1-Skp2 inhibition targets cancer stem cells. Asian J Androl.
15:717–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Gao D, Fukushima H, Inuzuka H, Liu
P, Wan L, Sarkar FH and Wei W: Skp2: A novel potential therapeutic
target for prostate cancer. Biochim Biophys Acta. 1825:11–17.
2012.PubMed/NCBI
|
|
5
|
Sonoda H, Inoue H, Ogawa K, Utsunomiya T,
Masuda TA and Mori M: Significance of skp2 expression in primary
breast cancer. Clin Cancer Res. 12:1215–1220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma XM, Liu Y, Guo JW, Liu JH and Zuo LF:
Relation of overexpression of S phase kinase-associated protein 2
with reduced expression of p27 and PTEN in human gastric carcinoma.
World J Gastroenterol. 11:6716–6721. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B, Ji LH, Liu W, Zhao G and Wu ZY:
Skp2-RNAi suppresses proliferation and migration of gallbladder
carcinoma cells by enhancing p27 expression. World J Gastroenterol.
19:4917–4924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei Z, Jiang X, Liu F, Qiao H, Zhou B,
Zhai B, Zhang L, Zhang X, Han L, Jiang H, et al: Downregulation of
Skp2 inhibits the growth and metastasis of gastric cancer cells in
vitro and in vivo. Tumor Biol. 34:181–192. 2013. View Article : Google Scholar
|
|
9
|
Tian YF, Chen TJ, Lin CY, Chen LT, Lin LC,
Hsing CH, Lee SW, Sheu MJ, Lee HH, Shiue YL, et al: SKP2
overexpression is associated with a poor prognosis of rectal cancer
treated with chemoradiotherapy and represents a therapeutic target
with high potential. Tumour Biol. 34:1107–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv A, Li Z, Tian X, Guan X, Zhao M, Dong B
and Hao C: SKP2 high expression, KIT exon 11 deletions, and
gastrointestinal bleeding as predictors of poor prognosis in
primary gastrointestinal stromal tumors. PLoS One. 8:e62912013.
View Article : Google Scholar
|
|
11
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao M, Yin H and Fei ZW: Clinical
application of microRNA in gastric cancer in Eastern Asian area.
World J Gastroenterol. 19:2019–2027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X, Li X and Yuan H: microRNAs in
gastric cancer invasion and metastasis. Front Biosci (Landmark Ed).
18:803–810. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen W, Tang Z, Sun Y, Zhang Y, Wang X,
Shen Z, Liu F and Qin X: miRNA expression profile in primary
gastric cancers and paired lymph node metastases indicates that
miR-10a plays a role in metastasis from primary gastric cancer to
lymph nodes. Exp Ther Med. 3:351–356. 2012.PubMed/NCBI
|
|
16
|
Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu
B, Yan M, Yu Y, Liu B and Zhu Z: MiR-133b is frequently decreased
in gastric cancer and its overexpression reduces the metastatic
potential of gastric cancer cells. BMC Cancer. 14:342014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei Z, Jiang X, Qiao H, Zhai B, Zhang L,
Zhang Q, Wu Y, Jiang H and Sun X: STAT3 interacts with Skp2/p27/p21
pathway to regulate the motility and invasion of gastric cancer
cells. Cell Signal. 25:931–938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hung WC, Tseng WL, Shiea J and Chang HC:
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and
invasion of lung cancer cells. Cancer Lett. 288:156–161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong F, Cao P, Yin Y, Xia S, Lai R and Liu
S: MicroRNAs in gastric cancer: From benchtop to bedside. Dig Dis
Sci. 59:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tapias A, Ciudad CJ, Roninson IB and Noe
V: Regulation of Sp1 by cell cycle related proteins. Cell Cycle.
7:2856–2867. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li
K, Zhou L, Sun Y, Li M, Zhou J, et al: miR-508-5p regulates
multidrug resistance of gastric cancer by targeting ABCB1 and
ZNRD1. Oncogene. 33:3267–3276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Wang J, Yang Y, Hao B, Wang R, Li
Y and Wu Q: Loss of has-miR-337-3p expression is associated with
lymph node metastasis of human gastric cancer. J Exp Clin Cancer
Res. 32:762013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan H, Wang S, Yu H, Zhu J and Chen C:
Molecular pathways and functional analysis of miRNA expression
associated with paclitaxel-induced apoptosis in hepatocellular
carcinoma cells. Pharmacology. 92:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lonjedo M, Poch E, Mocholí E,
Hernández-Sánchez M, Ivorra C, Franke TF, Guasch RM and Pérez-Roger
I: The Rho family member RhoE interacts with Skp2 and is degraded
at the proteasome during cell cycle progression. J Biol Chem.
288:30872–30882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fukuchi M, Masuda N, Nakajima M, Fukai Y,
Miyazaki T, Kato H and Kuwano H: Inverse correlation between
expression levels of p27 and the ubiquitin ligase subunit Skp2 in
early esophageal squamous cell carcinoma. Anticancer Res.
24:777–783. 2004.PubMed/NCBI
|
|
27
|
Harada K, Kawaguchi S Supriatno, Kawashima
Y, Itashiki Y, Yoshida H and Sato M: High expression of S-phase
kinase-associated protein 2 (Skp2) is a strong prognostic marker in
oral squamous cell carcinoma patients treated by UFT in combination
with radiation. Anticancer Res. 25:2471–2475. 2005.PubMed/NCBI
|
|
28
|
Wei S, Chu PC, Chuang HC, Hung WC, Kulp SK
and Chen CS: Targeting the oncogenic E3 ligase Skp2 in prostate and
breast cancer cells with a novel energy restriction-mimetic agent.
PLoS One. 7:e472982012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He W, Li Y, Chen X, Lu L, Tang B, Wang Z,
Pan Y, Cai S, He Y and Ke Z: miR-494 acts as an anti-oncogene in
gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol.
29:1427–1434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
−145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao Q, Cao Z, Tu C, Zhao Y, Liu H and
Zhang S: MicroRNA-146a acts as a metastasis suppressor in gastric
cancer by targeting WASF2. Cancer Lett. 335:219–224. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sanchez N, Gallagher M, Lao N, Gallagher
C, Clarke C, Doolan P, Aherne S, Blanco A, Meleady P, Clynes M and
Barron N: MiR-7 triggers cell cycle arrest at the G1/S transition
by targeting multiple genes including Skp2 and Psme3. PLoS One.
8:e656712013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qiang L, Hong L, Ningfu W, Huaihong C and
Jing W: Expression of miR-126 and miR-508-5p in endothelial
progenitor cells is associated with the prognosis of chronic heart
failure patients. Int J Cardiol. 168:2082–2088. 2013. View Article : Google Scholar : PubMed/NCBI
|
